DocGo Inc.: Amends credit agreement with term loans totaling $102,000,000

What happened DocGo Inc filed an 8-K reporting that on Oct 1, 2026 Hicuity Health, Inc. and Ambulnz Holdings, LLC (the Borrowers), DocGo, certain subsidiaries of Ambulnz as guarantors, the lenders party thereto and Perceptive Credit Holdings IV, LP as administrative agent entered into an Amended and Restated Credit Agreement and Guaranty. The Credit Agreement amends and restates the prior credit agreement dated Dec 6, 2022.

The filing also reports an Amended and Restated Security Agreement granting a first-priority security interest in substantially all personal property of the grantors, the issuance of a warrant to the administrative agent to purchase up to 4,000,000 shares of common stock at an exercise price of $0.5039 per share, termination of the existing revolving credit facility dated Aug 7, 2025 with Citibank, N.A., and that Ambulnz will begin managing Hicuity’s non-clinical operations effective Oct 1, 2026.

Key details

• Term loans: Term Loan A continued as outstanding term loans in the aggregate amount of $52,000,000; Term Loan B of $12,500,000 funded on the effective date; Term Loan C of $12,500,000 to be funded upon consummation of the Merger (or later at the Company’s option); Term Loan D delayed draw facility of $25,000,000 available through Dec 31, 2027, subject to conditions.
• Interest and repayment: interest at Term SOFR (subject to a floor of 3.50%) plus an applicable margin of 7.50%; no scheduled principal repayments prior to stated maturity; stated maturity date Dec 6, 2029.
• Warrant and security: warrant issued to Perceptive Credit Holdings IV, LP to purchase 4,000,000 shares at $0.5039 per share, exercisable through the tenth anniversary and subject to automatic exercise conditions; security agreement grants first-priority liens on substantially all personal property of the grantors.
• Other actions: the Company terminated its existing revolving credit facility dated Aug 7, 2025 with Citibank, N.A., discharging the guarantees and liens under that facility; Ambulnz will begin to manage Hicuity’s non-clinical operations effective Oct 1, 2026.

Why it may matter This filing reports Item 1.01 (entry into a material definitive agreement — the credit agreement, term loans and related documents), Item 1.02 (termination of a material definitive agreement — the prior revolving facility) and Item 8.01 (other events — Ambulnz managing Hicuity’s non-clinical operations). This filing does not show why the insider traded or why the company acted.